News for Oncternal Therapeutics, Inc. (ONCT)

SAN DIEGO, March 07, 2025 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. ( ONCT) (the ”œCompany”) today announced its intention to file a Form 25 Notific

**media[560520]**

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.99%

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 400 points on Monday. The Dow traded up 0.95% to 44,718.05 whil...

U.S. stocks traded mostly higher midway through trading, with the Dow Jones index gaining over 250 points on Monday. The Dow traded up 0.63% to 44,574.37 while...

U.S. stocks traded higher this morning, with the Dow Jones index gaining by more than 300 points on Monday. Following the market opening Monday, the Dow traded...

**media[443559]**

Grant Revenue: $0.8 million for the second quarter ended June 30, 2024.Total Operating Expenses: $9.7 million for the second quarter ended June 30, 2024.Resear

Aug 08, 2024 / 09:00PM GMTOperator Greetings, and welcome to the Oncternal Therapeutics second-quarter 2024 financial results call. (Operator Instructions) As a

ONCT Stock Touches 52-Week Low at $1.31 Amid Market Challenges

U.S. stocks traded higher toward the end of trading, with the Dow Jones index surging more than 200 points on Thursday. The Dow traded up 0.53% to 41,076.41 wh...

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining more than 50 points on Thursday. The Dow traded down 0.11% to 40,814.73 whil...

The metastatic prostate cancer market is driven by advancements in targeted therapies and immunotherapies, catering to a growing aging population. Early...

In this article, we will take a detailed look at the 10 Underperforming Stocks Insiders are Buying. For a quick overview of such stocks, read our article 5 Underperforming Stocks Insiders are Buying...

Shares of Ascent Industries Co. (NASDAQ: ACNT) rose sharply in pre-market trading as the company reported the sale of the business of Specialty Pipe & Tube for around $55 million in an all-cash deal. Ascent Industries shares surged 7.4% to $8.69 in pre-market trading.

Shares of RayzeBio, Inc. (NASDAQ: RYZB) rose sharply during Tuesday’s session after the company announced that it will be acquired by Bristol Myers Squibb for $62.50 per share in cash in a deal worth $4.1 billion. RayzeBio shares gained 100% to $61.38 on Tuesday.

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 100 points on Tuesday. The Dow traded up 0.34% to 37,511.87 while the NASDAQ rose 0.43% to 15,057.13. The S&P 500 also rose, gaining, 0.34% to 4,770.79.

The marginal zone lymphoma pipeline possesses potential drugs in mid-stage developments to be launched in the near future. The total marginal zone lymphoma...

The DLBCL market has a diverse pipeline, with the emergence of novel classes such as bi-specific antibodies, cancer vaccines, and allogeneic CAR-Ts in the...